so here are my results for mito variations:
1)MT-CYB rs3088309 ....but it has been merged into rs527236209 Likely pathogenic. Ovarian cancer.
2)MT ND5 rs28359178 . leber's optic atrophy.NADH dehydrogenase (complex 1)
Hello
@aquariusgirl
The MT-CYB rs3088309 which has been merged into rs527236209 is one of those spots with multiple issues where the scientists have screwed up the numbering on various instances and need to pull out the mis-labels and confusion before anyone takes it seriously. It's just part of being on the forefront of the infancy curve of genetics.
For example, going into my 23andme results for MT-CYB, 23andme shows me as:
"MT-CYB, rs3088309, position 15452, with the variants being A or C, and I'm an A"
In fact, out of the 8 people I checked on 23andme, 7 of them have this mutation per 23andme. For example, it says both of my parents have it. Highly unusual. So that's an indication that it could be a mis-call or a position issue. Of course it could indicate my dad has that mutation also from the other side of the family. But the plot gets thicker.
The problem is that if you go to the NIH site for the merged into rs# link, you'll find the position for this location is 15452. Yet, when I type rs3088309 into the search box on Enlis, it comes up with none of the 23andme data for that rs# per 23andme's raw data, but it does come up for one person with WGS for this rs#, except it's for position 15,453. So the position is moved over here by one.
https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=527236209
Enlis has the Allele Freq for position 15,453 at 0.00% rare. Enlis has the Allele Freq for position 15,452 at 9.37% which is not so rare.
Part of this screw-up is due to the old reference genome hg19 using a mitochondrial genome reference that was off in most locations by 1 or 2 (depending upon where it was) and also it has a few locations where the position was off. Most programs try to compensate for these issues. Yet, not all are picked up by all programs.
While Enlis states that the allele frequency for this location is rare, if you go down to the bottom of the page for that NIH reference, it shows that it's not so rare. There is a lot of conflicting information because the original use of the wrong reference genome by everyone for years. Here is what the NIH has for position 15,453.
https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=527236184
I had a Whole Genome Sequencing on myself (WGS) that called this position 15,453 as a mutation for me. Yet, they used the wrong reference genome hg19. When I backed it out of the original BAM file to the original FASTQ file and then reran it with the newer (revised reference genome) used by all the mito specialists, this mutations didn't show up.
So to recap the position was merged. Bad sign. For rs3088309 (merged into rs527236209) it should show up as 15,452. Yet inputting rs3088309 brings up position 15,453 for a WGS on Enlis (but not those with the mutation per 23andme raw data entered into 23andme). This mutation was also an issue for the majority of companies that used hg19 as a reference genome for Mitochondria. Surprisingly, there are still some big companies still using reference genome hg19 today when doing WGS and WES, not realizing the issue with mitochondrial reference genome being off.
Therefore, it's important to take this location with a grain of salt.
Any location that has been merged will often have issues like this that will still need to shake out through the system and medical community. It's part of being at the forefront of genetics infancy.
So please take this specific mutation with a grain of salt. A mito specialist would have to rerun it using a correct reference.